118 related articles for article (PubMed ID: 12836589)
1. Hemiparkinson-hemiatrophy syndrome: a transcranial magnetic stimulation study.
Nardone R; Lochner P; Tezzon F
Electromyogr Clin Neurophysiol; 2003 Jun; 43(4):235-40. PubMed ID: 12836589
[TBL] [Abstract][Full Text] [Related]
2. Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: a prospective 12-month paired TMS study.
Bares M; Kanovský P; Rektor I
Parkinsonism Relat Disord; 2007 Dec; 13(8):489-94. PubMed ID: 17449315
[TBL] [Abstract][Full Text] [Related]
3. Study of central motor functions using magnetic stimulation in Parkinson's disease.
Diószeghy P; Hidasi E; Mechler F
Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):101-5. PubMed ID: 10207679
[TBL] [Abstract][Full Text] [Related]
4. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
[TBL] [Abstract][Full Text] [Related]
5. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
[TBL] [Abstract][Full Text] [Related]
6. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.
Koch G; Brusa L; Carrillo F; Lo Gerfo E; Torriero S; Oliveri M; Mir P; Caltagirone C; Stanzione P
Neurology; 2009 Jul; 73(2):113-9. PubMed ID: 19597133
[TBL] [Abstract][Full Text] [Related]
8. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
[TBL] [Abstract][Full Text] [Related]
9. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
[TBL] [Abstract][Full Text] [Related]
10. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes.
Wolters A; Classen J; Kunesch E; Grossmann A; Benecke R
Mov Disord; 2004 May; 19(5):518-28. PubMed ID: 15133815
[TBL] [Abstract][Full Text] [Related]
11. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation.
Caramia MD; Palmieri MG; Desiato MT; Boffa L; Galizia P; Rossini PM; Centonze D; Bernardi G
Clin Neurophysiol; 2004 Apr; 115(4):956-65. PubMed ID: 15003779
[TBL] [Abstract][Full Text] [Related]
12. Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy.
Marini P; Ramat S; Ginestroni A; Paganini M
Neurol Sci; 2003 Oct; 24(3):184-5. PubMed ID: 14598078
[TBL] [Abstract][Full Text] [Related]
13. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
[TBL] [Abstract][Full Text] [Related]
14. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
Devos D; Defebvre L
Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
[TBL] [Abstract][Full Text] [Related]
15. Neural response to transcranial magnetic stimulation in adult hypothyroidism and effect of replacement treatment.
Rizzo V; Crupi D; Bagnato S; Quartarone A; Benvenga S; Bartolone L; Ghilardi MF; Trimarchi F; Girlanda P; Battaglia F
J Neurol Sci; 2008 Mar; 266(1-2):38-43. PubMed ID: 17900624
[TBL] [Abstract][Full Text] [Related]
16. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation.
Lefaucheur JP
Clin Neurophysiol; 2005 Feb; 116(2):244-53. PubMed ID: 15661100
[TBL] [Abstract][Full Text] [Related]
17. [Long chronic course of hemiparkinson-plus with l-dopa maintained response].
Arias M; Requena I; Lema C
Rev Neurol; 1998 Jul; 27(155):94-5. PubMed ID: 9674037
[TBL] [Abstract][Full Text] [Related]
18. Repetitive transcranial magnetic stimulation (rTMS): insights into the treatment of Parkinson's disease by cortical stimulation.
Lefaucheur JP
Neurophysiol Clin; 2006; 36(3):125-33. PubMed ID: 17046607
[TBL] [Abstract][Full Text] [Related]
19. Corticospinal physiology in patients with Prader-Willi syndrome: a transcranial magnetic stimulation study.
Civardi C; Vicentini R; Grugni G; Cantello R
Arch Neurol; 2004 Oct; 61(10):1585-9. PubMed ID: 15477513
[TBL] [Abstract][Full Text] [Related]
20. Proximal conduction abnormality of the facial nerve in Miller Fisher syndrome: a study using transcranial magnetic stimulation.
Arányi Z; Szabó G; Szepesi B; Folyovich A
Clin Neurophysiol; 2006 Apr; 117(4):821-7. PubMed ID: 16442344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
